CARE Ratings share news, announcements and annual reports
NSE: CARERATINGBSE: 534804Capital MarketsSmall Cap
CARE Ratings Limited · Formerly Credit Analysis and Research · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2012
Last close ₹1,658.00up ₹37.80 (2.33%)BSE ₹1,658.55
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,620.20.
30 Oct: open ₹1,685.00, high ₹1,709.90, low ₹1,629.00
52-week range of traded prices to 30 Oct 2026
₹1,392.70Low, 23 Mar 2026₹1,838.00High, 15 May 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,994 Cr794th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 25.90
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.98
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.33%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,28,26741.0% delivered
CARE Ratings disputes and clarifications
24 filed, newest first.
Mar 2026
25 Mar · Legal
Feb 2026
18 Feb · Legal
Jan 2025
25 Jan · Legal
Jul 2022
14 Jul · Legal
The exchange asked on 13 Jul 2022
Dec 2020
4 Dec · Legal
The exchange asked on 3 Dec 2020
Nov 2020
12 Nov · Legal
Exchange has sought clarification from CARE Ratings Limited for the quarter ended 30-Sep-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: 1. Machine Readable Form / Legible copy of Financial Results not submitted.The response of the Company is awaited.
Sep 2020
24 Sep · Legal
Exchange has sought clarification from CARE Ratings Limited for the quarter ended 30-Jun-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: 1. Machine Readable Form / Legible copy of Financial Results not submitted. The response of the Company is awaited.
Jul 2020
29 Jul · Legal
Exchange has sought clarification from CARE Ratings Limited with respect to announcement dated 25-Jul-2020, regarding the SEBI Adjudicating order dated 24-Jul-2020. On basis of above the Company is required to clarify following: 1. Brief details of the regulatory action(s) with impact.The response of the Company is awaited.21 Jul · Legal
The exchange asked on 21 Jul 2020
Feb 2020
19 Feb · Legal
Exchange has sought clarification from CARE Ratings Limited with respect to announcement dated 11-Feb-2020, regarding Change in Director(s) of the company. On basis of above the Company is required to clarify following: 1. No other material reasons other than provided. The response of the Company is awaited.
Jan 2020
2 Jan · Legal
The exchange asked on 31 Dec 2019
May 2019
29 May · Legal
Exchange has sought clarification from CARE Ratings Limited with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
Apr 2019
Jun 2018
May 2018
30 May · Legal
Exchange had sought clarification from CARE Ratings Limited with respect to announcement dated 23-May-2018, regarding regarding Outcome of Board Meeting held on May 22, 2018. On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is as follow- Brief Profile Of the Director Appointed has been uploaded under the head Outcome uploaded on May 23, 2018 at 01.31 a.m.29 May · Legal
Exchange has sought clarification from CARE Ratings Limited with respect to announcement dated 23-May-2018, regarding regarding Outcome of Board Meeting held on May 22, 2018.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.23 May · Legal
Exchange has sought clarification from CARE Ratings Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
Oct 2016
Sep 2016
30 Sep · Legal
Exchange has sought clarification from Credit Analysis And Research Limited with respect to announcement dated 28-Sep-2016, regarding "Credit Analysis And Research Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on September 27, 2016 accorded its approval : - 1) To invest approx. Rs. 1.60 crores (NR 2.55 crores) i.e. 51% of the total paid up share capital of approx Rs. 3.125 crores (NR 5 crores) in the Joint Venture Company with Vishal Group Limited and Emerging Nepal Limited to start a credit rating agency in Nepal subject to the regulatory approvals. 2) To invest Rs. 4,45,00,000/- in the share capital of its wholly owned subsidiary, CARE Advisory Research And Training Limited subject to the regulatory approvals.".On basis of above the Company is required to clarify following:1. Domestic/international;2. Share exchange ratio / JV ratio;3. Scope of business operation of agreement / JV4. Details of consideration paid / received in agreement / JV;5. Significant terms and conditions of agreement / JV in brief;6. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at arms length";7. Size of the entity(ies);8. Rationale and benefit expected.The response of the Company is awaited.